# Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy

> **NCT00624910** · PHASE2 · COMPLETED · sponsor: **Innocoll** · enrollment: 54 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Bupivacaine Collagen Sponge (CollaRx®)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00624910
- **Lead sponsor:** Innocoll
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-27
- **Primary completion:** 2008-09-05
- **Final completion:** 2008-09-05
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2021-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00624910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00624910, "Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00624910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*